The Zacks Analyst Blog Highlights: AmerisourceBergen, Walgreens, Cardinal
Health, CVS Caremark and Duke Energy
CHICAGO, April 4, 2013
CHICAGO, April 4, 2013 /PRNewswire/ --Zacks.com announces the list of stocks
featured in the Analyst Blog. Every day the Zacks Equity Research analysts
discuss the latest news and events impacting stocks and the financial markets.
Stocks recently featured in the blog include AmerisourceBergen Corp.
(NYSE:ABC), Walgreens (NYSE:WAG), Cardinal Health (NYSE:CAH), CVS Caremark
Corporation (NYSE:CVS) and Duke Energy Corporation (NYSE:DUK).
Get the most recent insight from Zacks Equity Research with the free Profit
from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Wednesday's Analyst Blog:
AmerisourceBergen Aims to Offload Biz
AmerisourceBergen Corp. (NYSE:ABC) recently announced that it has inked a
definitive agreement to sell its contract packaging unit, AndersonBrecon, to a
conglomerate of an investor group led by Frazier Healthcare VI, L.P for
approximately $308 million in cash.
The conglomerate includes affiliates of Greenspring Associates, QIC Global
Private Equity and Thomas McNerney & Partners and has been formed solely for
the acquisition of AndersonBrecon.
The results of AndersonBrecon are reported as discontinued operations.
Consequently, the sale of this business therefore will not impact
AmerisourceBergen's guidance for fiscal 2013.
We note that AmerisourceBergen has been streamlining its portfolio in recent
times. The company reportedly sold its Canadian pharmaceutical distribution
business, AmerisourceBergen Canada Corporation (ABCC) to Kohl & Frisch Limited
for approximately $80 million – $100 million. AmerisourceBergen will however
retain its specialty business unit in Canada.
Following the announcement to sell its Canadian Pharmaceutical Distribution
Business on Mar 28, 2013, AmerisourceBergen revised its guidance for 2013.
AmerisourceBergen now expects revenues in 2013 to grow by roughly 8% to 10%
compared to the previous guidance of 8% – 11% growth.
AmerisourceBergen increased its earnings guidance for fiscal 2013 to $3.04 –
$3.14 from the earlier projected range of $2.96 – $3.06.
We believe the company is well positioned for growth given the strong
performance of its generics business. In Mar 2013, the company struck a
10-year deal with Walgreens (NYSE:WAG) which is expected to add approximately
$2 billion to top line in fiscal 2013.
We note that Walgreens chose AmerisourceBergen over peer Cardinal Health
(NYSE:CAH) with whom it already had a pharmaceutical distribution contract but
decided not to renew the same.
AmerisourceBergen carries a Zacks Rank #3 (Hold). Right now, CVS Caremark
Corporation (NYSE:CVS) looks well placed with a Zacks Rank #2 (Buy).
Duke Energy, PUCO Settle Rate Hike Case
Duke Energy Ohio, a unit of Duke Energy Corporation (NYSE:DUK), has reached a
settlement with the Staffs of the Public Utilities Commission of Ohio ("PUCO")
over its Jun 2012 request to hike its rates.
Under the latest agreement, the annual increment in revenue for the
Cincinnati-based utility is $49 million for an average 2.9% increase in
electric bills. This is equivalent to a monthly hike of $3.72 for a normal
Ohio residential electric customer. After the necessary permit, the electric
rate increases would take effect mid-year. The recourse to rate hike
applications is a usual practice by energy companies to recover the huge
capital investments they make.
However, the settlement leaves gas rate increases unresolved due to the
lawsuits over environmental remediation costs related to Duke Energy's former
manufactured gas plant locations.
Per the approval, PUCO has approved a return on equity ("ROE") of 9.84% for
both the electric and natural gas distribution cases. The approval includes a
capital structure of 53.3% equity and 46.7% debt. This is in line with the
company's present capital structure. Duke Energy Ohio has also decided to set
aside about $700,000 annually for its low income weatherization and fuel fund.
This rate hike approval will aid the company to recover its investments. Over
the last couple of years, Duke Energy has exhausted a substantial amount to
improve the natural gas delivery system. This is essential for improving
efficiency, cutting fuel consumption and, thereby, lowering the cost of
Recently, another affiliate of Duke Energy Corporation − Duke Energy Carolinas
− requested the South Carolina Utilities Commission ("PSCSC") to make a 15.1%
rate increase. If approved, the rate increase is expected to generate $220
million more from the customers.
We view Duke Energy − the largest electric power holding company in the U.S. −
as a well-managed and high-quality energy provider in high-growth areas.
However, the present unfavorable macro backdrop, predominantly fossil-fuel
based generation assets, tepid demand for electricity, and pending regulatory
cases keep us on the sidelines.
Want more from Zacks Equity Research? Subscribe to the free Profit from the
Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative
analysis to help investors know what stocks to buy and which to sell for the
Continuous coverage is provided for a universe of 1,150 publicly traded
stocks. Our analysts are organized by industry which gives them keen insights
to developments that affect company profits and stock performance.
Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the
latest analysis from Zacks Equity Research. Subscribe to this free newsletter
Zacks.com is a property of Zacks Investment Research, Inc., which was formed
in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in
stock market data that would lead to superior investment results. Amongst his
many accomplishments was the formation of his proprietary stock picking
system; the Zacks Rank, which continues to outperform the market by nearly a 3
to 1 margin. The best way to unlock the profitable stock recommendations and
market insights of Zacks Investment Research is through our free daily email
newsletter; Profit from the Pros. In short, it's your steady flow of
Profitable ideas GUARANTEED to be worth your time! Register for your free
subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance
numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook:
Disclaimer: Past performance does not guarantee future results. Investors
should always research companies and securities before making any investments.
Nothing herein should be construed as an offer or solicitation to buy or sell
Zacks Investment Research
800-767-3771 ext. 9339
SOURCE Zacks Investment Research, Inc.
Press spacebar to pause and continue. Press esc to stop.